Stay Informed. Stay Healthy. Stay Safe.

Awareness Globe Icon

Awareness

help spread the word about sickle cell disease

Education Bulb Icon

Education

learn about the impact of sickle cell disease

Hope Heart Icon

Hope

find out about research for new treatments and a universal cure

Interactive and informative monthly sessions that connect SiNERGe CBOs and leaders across the region

January 2022

Grant Writing Series Part I

Writing a Needs Statement

Ginger Davis, Executive Director

Mark Goodwin, Project Manager

Sickle Cell Thalassemia Patients Network

 

ECHO 2.0 is supported by HRSA. The views expressed are those of the speaker(s) and participants and do not represent official views of, nor an endorsement by HRSA, Johns Hopkins or the WEPSCF. ECHO 2.0 is presented for information purposes only. Individuals should seek advice, guidance and direction from their qualified health care provider.

INDIVIDUALS LIVING WITH SCD IN THE U.S.

HOSPITALIZATIONS ANNUALLY DUE TO SCD IN THE U.S.

NEW DRUGS APPROVED BY FDA SINCE 2017

THERAPIES CURRENTLY IN PHASE III CLINICAL TRIALS